Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies

被引:43
作者
Keelan, JA
Taylor, R
Schellenberg, JC
Groome, NP
Mitchell, MD
North, RA
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Liggins Inst, Auckland 1, New Zealand
[2] Univ Auckland, Fac Med & Hlth Sci, Div Pharmacol & Clin Pharmacol, Auckland 1, New Zealand
[3] Univ Auckland, Fac Med & Hlth Sci, Div Obstet & Gynecol, Auckland 1, New Zealand
[4] Maternite Geneve, Clin & Policlin Obstet, Geneva, Switzerland
[5] Oxford Brookes Univ, Sch Biol & Mol Sci, Ctr Prot & Peptides, Oxford OX3 0BP, England
关键词
D O I
10.1016/S0029-7844(01)01674-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To determine whether maternal serum activin A, inhibin A, and follistatin concentrations in idiopathic small for gestational age (SGA) pregnancies are similar to those in normal pregnancies or elevated as in preeclampsia. METHODS: Maternal serum activin A, inhibin A, and follistatin concentrations were determined in 1) nulliparous women with idiopathic SGA (birth weight <10th percentile; n = 18), preeclampsia (systolic blood pressure greater than or equal to140 mmHg or diastolic blood pressure greater than or equal to90 mmHg plus proteinuria greater than or equal to2+ or >0.3g/24h; n = 22), and normotensive controls, matched for gestational age at sampling (n = 22), and 2) a longitudinal series of samples collected at five intervals throughout pregnancy from nulliparous women with idiopathic SGA (n = 19), preeclampsia (n = 22), preeclampsia plus SGA (n = 15), or who had uncomplicated pregnancies (n = 20). RESULTS: Serum concentrations of activin A and inhibin A were similar in idiopathic SGA pregnancies to controls. In preeclampsia, activin A and inhibin A levels were markedly increased compared with controls or women with idiopathic SGA (P < .001), particularly in those with early-onset disease. Follistatin concentrations were only modestly (<twofold) elevated in preeclampsia (P < .001). In the longitudinal study, serum activin A or inhibin A concentrations were increased in women who later developed preeclampsia, whereas in women with idiopathic SGA pregnancy, a small overall increase in activin A levels was observed. CONCLUSIONS: In contrast to women with preeclampsia, normotensive women with SGA pregnancies do not have markedly elevated circulating levels of activin A and inhibin A. These data support the hypothesis that increased serum activin A concentrations in preeclampsia may be a manifestation of maternal disease rather than just a marker of abnormal placentation. (C) 2002 by the American College of Obstetricians and Gynecologists.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 27 条
[21]   INHIBIN AND ACTIVIN MODULATE HUMAN MONOCYTE CHEMOTAXIS AND HUMAN LYMPHOCYTE INTERFERON-GAMMA PRODUCTION [J].
PETRAGLIA, F ;
SACERDOTE, P ;
COSSARIZZA, A ;
ANGIONI, S ;
GENAZZANI, AD ;
FRANCESCHI, C ;
MUSCETTOLA, M ;
GRASSO, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (02) :496-502
[22]   Follistatin: A multifunctional regulatory protein [J].
Phillips, DJ ;
de Kretser, DM .
FRONTIERS IN NEUROENDOCRINOLOGY, 1998, 19 (04) :287-322
[23]   Preeclampsia: An excessive maternal inflammatory response to pregnancy [J].
Redman, CWG ;
Sacks, GP ;
Sargent, IL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (02) :499-506
[24]   Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies [J].
Silver, HM ;
Lambert-Messerlian, GM ;
Star, JA ;
Hogan, J ;
Canick, JA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (05) :1131-1137
[25]  
Sugino Hiromu, 1997, Journal of Medical Investigation, V44, P1
[26]   Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia [J].
Taylor, RN ;
de Groot, CJM ;
Cho, YK ;
Lim, KH .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1998, 16 (01) :17-31
[27]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC CELL-LINE HL-60 BY ACTIVIN EDF [J].
YAMADA, R ;
SUZUKI, T ;
HASHIMOTO, M ;
ETO, Y ;
SHIOKAWA, K ;
MURAMATSU, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (01) :79-85